Glooko reports no severe hypoglycaemia in 267-patient EndoTool IV labour and delivery analysis
Glooko reports zero severe hypoglycaemia events in 267 patients using EndoTool IV during delivery, but neonatal outcomes remain unreported.
Medical Devices & Diagnostics
Pharma & Biotech
Ono Pharmaceutical’s ONO-1110 missed three pain trial endpoints, so why is the drug still moving forward?
Ono Pharmaceutical's ONO-1110 missed three pain trial endpoints but showed exploratory signals, prompting further studies in selected conditions.
Pharma & Biotech
Pythia Labs launches AI antibody platform after generating binders against 15 of 22 therapeutic targets
Pythia Labs launches Pythia-1 after designing antibodies against 15 of 22 targets, including seven GPCRs, but clinical validation lies ahead.
Pharma & Biotech
Forlong Biotechnology doses first patient in Australian Phase 1 trial of subcutaneous FL115
Forlong Biotechnology begins Australian Phase 1 testing of subcutaneous FL115, targeting lower peak exposure and improved immune activation.
Pharma & Biotech
Natera’s Signatera Genome separates bladder cancer patients into 91%, 81% and 55% survival groups, but can MRD guide treatment?
Natera reports 91% two-year event-free survival in persistently ctDNA-negative VOLGA patients, strengthening MRD research in bladder cancer.
Pharma & Biotech
Neurogene reports rapid MECP2 expression and new gene regulation data for NGN-401 in Rett syndrome
Neurogene reports rapid MECP2 expression and new regulation data for NGN-401, strengthening its Rett syndrome research ahead of 2027 results.
Pharma & Biotech
Dyno Therapeutics reports 152-fold brain transduction improvement and new immune-evasive AAV capsid data at ESGCT 2026
Dyno Therapeutics reports 152-fold higher brain transduction than AAV9 in primates, plus new muscle and antibody-evasive capsid data.
Pharma & Biotech
Rumi Therapeutics signs option agreement for IND-ready RTX-7340 PDE2 inhibitor in Fragile X syndrome
Rumi Therapeutics secures an option to license RTX-7340 for Fragile X syndrome, with preclinical EEG findings supporting clinical development.
Medical Devices & Diagnostics
Powerful Medical secures CPT code 1139T for Queen of Hearts AI ECG after FDA authorisation
Powerful Medical secures CPT code 1139T for Queen of Hearts AI ECG, opening a US billing pathway while reimbursement remains unresolved.
Medical Devices & Diagnostics
Kivo Health raises $10m Series A led by Allumia Ventures to expand AI-powered care for chronic lung disease
Kivo Health raises $10m to expand virtual COPD care, backed by early rehabilitation outcomes and projected savings that still need validation.